The Best Penny Stock on Robinhood Offers 500% Upside

Robinhood's introduction of no-fee trading revolutionized the digital brokerage industry.

That's been great for consumers. But penny stock investors have been left out in the cold. Robinhood doesn't let you trade stocks listed on certain over-the-counter exchanges, like the Pink Sheets, leaving thousands of penny stocks off the table.

But that doesn't mean there aren't plenty of excellent penny stocks to buy on Robinhood.

Look at Eldorado Gold Corp. (NYSE: EGO). This Robinhood stock saw peak gains of 240% last year.

FlexShopper Inc. (NASDAQ: FPAY) shares rocketed 250% higher in 2019.

And Novume Solutions Inc. (NASDAQ: REKR) saw peak gains of 480%.

You simply don't have to miss out on penny stock profits just because Robinhood doesn't offer the entire universe of penny stocks.

There are even more with future upside potential you can buy right now.

We've done the research and found one of the best penny stocks you can buy right now that has even higher upside than the big winners we just showed you.

That means you can buy a top penny stock with no trading free on Robinhood with 500% growth potential...

This Is the Best Penny Stock on Robinhood

[mmpazkzone name="in-story" network="9794" site="307044" id="137008" type="4"]

Lineage Cell Therapeutics Inc. (NYSEAMERICAN: LCTX) trades for just $1 a share and is available on Robinhood.

And shares could soar to $6 in 2020...

Lineage is a clinical-stage biotech company that focuses on cell therapy to treat a range of health problems. It is currently in the clinical stage for three cell replacement therapies treating cancer, spinal cord injuries, and an age-related eye disease.

Dry age-related macular degeneration is the leading cause of irreversible vision damage and loss in the United States. Lineage's OpRegen cell replacement therapy has been granted Fast Track designation by the FDA and is now in phase 2 trials.

The potential for one or all of these treatments to pass clinical trials and go onto the market could springboard this stock through the roof.

Analysts surveyed by Yahoo Finance predict a 12-month price of $6 a share and an average price target of $4 a share, a 300% gain.

America's Favorite Angel Investor Shows How Easy It Is for Anyone to Invest in Ground-Floor Startups

You've probably seen stories about this person or that person making an absolute fortune from some unknown startup suddenly becoming a household name... like Uber, Airbnb, SpaceX, or Bird.

Now, it's your turn.

Shark Tank's Robert Herjavec is showing how easy it is for anyone to turn as little as $50 into what can be life-changing windfalls... all from investing in startups.

Click here to learn more...

Follow Money Morning onFacebook and Twitter.